Increased Confidence in Deduplication of Drug Safety Reports with Natural Language Processing of Narratives at the US Food and Drug Administration

Increased Confidence in Deduplication of Drug Safety Reports with Natural Language Processing of Narratives at the US Food and Drug Administration

The US Food and Drug Administration (FDA) receives millions of postmarket adverse event reports for drug and therapeutic biologic products every year. One of the most salient issues with these submissions is report duplication, where an adverse event experienced by one patient is reported multiple t...

Full description

Saved in:
Bibliographic Details
Main Authors: Kory Kreimeyer, Oanh Dang, Jonathan Spiker, Paula Gish, Jessica Weintraub, Eileen Wu, Robert Ball, Taxiarchis Botsis
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Drug Safety and Regulation
Subjects:
pharmacovigilance
deduplication
decision support
natural language processing
safety surveillance
Online Access:https://www.frontiersin.org/articles/10.3389/fdsfr.2022.918897/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fdsfr.2022.918897/full

Similar Items